PMID- 32586744
OWN - NLM
STAT- MEDLINE
DCOM- 20201105
LR  - 20210110
IS  - 1878-0938 (Electronic)
IS  - 1553-8389 (Print)
IS  - 1878-0938 (Linking)
VI  - 21
IP  - 8
DP  - 2020 Aug
TI  - Coronary and Structural Heart Disease Interventions During COVID-19 Pandemic: A 
      Road Map for Clinicians and Health Care Delivery Systems.
PG  - 939-945
LID - S1553-8389(20)30362-6 [pii]
LID - 10.1016/j.carrev.2020.06.013 [doi]
AB  - BACKGROUND: Because of the COVID-19 pandemic, cath labs have had to modify their 
      workflow for elective and urgent patients. METHODS: We surveyed 16 physicians 
      across 3 hospitals in our healthcare system to address COVID-19 related concerns 
      in the management of interventional and structural heart disease patients, and to 
      formulate system wide criteria for deferring cases till after the pandemic. 
      RESULTS: Our survey yielded common concerns centered on the need to protect 
      patients, cath lab staff and physicians from unnecessary exposure to COVID-19; 
      for COVID-19 testing prior to arrival to the cath lab; for clear communication 
      between the referring physician and the interventionalist; but there was initial 
      uncertainty among physicians regarding the optimal management of ST elevation 
      myocardial infarction (STEMI; percutaneous coronary intervention versus 
      thrombolytics). Patients with stable angina and hemodynamically stable acute 
      coronary syndromes were deemed suitable for initial medical management, except 
      when they had large ischemic burden. Most transcatheter aortic valve 
      implantations (TAVI) were felt appropriate for postponement except in symptomatic 
      patients with aortic valve area <0.5 cm(2) or recent hospitalization for heart 
      failure (HF). Most percutaneous mitral valve repair (pMVR) procedures were felt 
      appropriate for postponement except in patients with HF. All left atrial 
      appendage closure (LAAC) and patent foramen ovale (PFO)/atrial septal defect 
      (ASD) closure procedures were felt appropriate for postponement. CONCLUSION: Our 
      survey of an experienced team of clinicians yielded concise guidelines to direct 
      the management of CAD and structural heart disease patients during the initial 
      phases of the COVID-19 pandemic.
CI  - Copyright (c) 2020 Elsevier Inc. All rights reserved.
FAU - Harjai, Kishore J
AU  - Harjai KJ
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America. 
      Electronic address: kjharjai@geisinger.edu.
FAU - Agarwal, Shikhar
AU  - Agarwal S
AD  - Geisinger Medical Center, Danville, PA, United States of America.
FAU - Bauch, Terry
AU  - Bauch T
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Bernardi, Mark
AU  - Bernardi M
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Casale, Alfred S
AU  - Casale AS
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Green, Sandy
AU  - Green S
AD  - Geisinger Medical Center, Danville, PA, United States of America.
FAU - Harostock, Michael
AU  - Harostock M
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Ierovante, Nicholas
AU  - Ierovante N
AD  - Geisinger Community Medical Center, Scranton, PA, United States of America.
FAU - Mascarenhas, Vernon
AU  - Mascarenhas V
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Matsumura, Martin
AU  - Matsumura M
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Nawaz, Yassir
AU  - Nawaz Y
AD  - Geisinger Community Medical Center, Scranton, PA, United States of America.
FAU - Scott, Thomas
AU  - Scott T
AD  - Geisinger Medical Center, Danville, PA, United States of America.
FAU - Singh, Deepak
AU  - Singh D
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Stella, Joseph J
AU  - Stella JJ
AD  - Geisinger Community Medical Center, Scranton, PA, United States of America.
FAU - Vijayaraman, Pugazhendi
AU  - Vijayaraman P
AD  - Geisinger Wyoming Valley Hospital, Wilkes-Barre, PA, United States of America.
FAU - Yost, Gregory
AU  - Yost G
AD  - Geisinger Medical Center, Danville, PA, United States of America.
FAU - Blankenship, James C
AU  - Blankenship JC
AD  - Geisinger Medical Center, Danville, PA, United States of America.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
DEP - 20200610
PL  - United States
TA  - Cardiovasc Revasc Med
JT  - Cardiovascular revascularization medicine : including molecular interventions
JID - 101238551
SB  - IM
MH  - *Betacoronavirus
MH  - COVID-19
MH  - Cardiac Surgical Procedures/*methods
MH  - Comorbidity
MH  - Coronavirus Infections/*epidemiology
MH  - Delivery of Health Care/*methods
MH  - Female
MH  - Heart Diseases/epidemiology/*surgery
MH  - Humans
MH  - Male
MH  - Pandemics
MH  - Pneumonia, Viral/*epidemiology
MH  - SARS-CoV-2
PMC - PMC7286249
OTO - NOTNLM
OT  - COVID
OT  - Cath lab
OT  - Structural
EDAT- 2020/06/27 06:00
MHDA- 2020/11/06 06:00
PMCR- 2020/06/10
CRDT- 2020/06/27 06:00
PHST- 2020/04/23 00:00 [received]
PHST- 2020/05/18 00:00 [revised]
PHST- 2020/06/08 00:00 [accepted]
PHST- 2020/06/27 06:00 [pubmed]
PHST- 2020/11/06 06:00 [medline]
PHST- 2020/06/27 06:00 [entrez]
PHST- 2020/06/10 00:00 [pmc-release]
AID - S1553-8389(20)30362-6 [pii]
AID - 10.1016/j.carrev.2020.06.013 [doi]
PST - ppublish
SO  - Cardiovasc Revasc Med. 2020 Aug;21(8):939-945. doi: 10.1016/j.carrev.2020.06.013. 
      Epub 2020 Jun 10.